节点文献
肝癌门静脉瘤栓的经肝动脉碘油化疗栓塞
Treatment of Portal Vein Tumor Thromhosis in Patients with Hepatocellular Carcinoma by Transcatheter Arterial Lipiodol Chemo-embolization
【摘要】 20例原发性肝癌,门静脉瘤栓位于右支者7例、左支1例、主于4例、主干+右支8例。经肝动脉碘油化疗栓塞(Lp-TACE)后,肝区平片和CT平扫显示瘤栓内Lp积聚呈A型者9例、B型6例和C型5例。全组瘤栓缩小有效率40%,平均生存期8.2个月,累积生存率6个月45%、1年20%、2年10%。A型瘤栓缩小有效率77.8%,平均生存期12.7个月,累积生存率6个月77.8%、1年44.4%和2年22.2%明显高于B型和C型。表明Lp-TACE对部分肝癌门静脉瘤栓病人特别是Lp呈A型积聚者是较有效的方法。
【Abstract】 This paper reported 20 cases of hepatocellular carcinoma with portal vein tumor thrombosis of which 7 cases presented tumor lhrornbus growing into the right branch,1 case into hte left branch,4 cases into the main trunk and 8 cases involving both the right branch and the main trunk.After transcatheter hepatic arterial lipiodol chemo-embolization(Lp-TACE),plain film of ab-domen and CT scan disclosed three type of accumulation of lipiodol in the tumor thrombus,including Atype (columnar or oval, homoge neous type) in 9 cases,B type(scanty linear or speckled type)in 6cases and C type(no lipiodal deposition)in 5 cases. In all patients,the effective regression rate of tumor thrombus was 40%。 The average survival time was 8;2 months,the cumulative survival rate was 45%for 6 months, 20%for 1 year and 10%for 2 years. In A type of patients,the effective re-gression of tumor thrombus was 77.8%,the average survival time was 12.7 months, the cumulative survival rate was 77.8%for 6 months, 44.4%for 1 year,and 22.2%for 2 years, demonstrating that the result with type A was better than with B and C types of patients.It was suggested by the authors that Lp-TACE was an effective method of treatment for selective patients of hepatocellular carcinoma with portal vein tumor thrombosis,especially for A type of cases.
【Key words】 Hepatic tumor Portal vein Tumor thrombosis Lipiodol Emboliza-tion; therapeutic;
- 【文献出处】 中华放射学杂志 ,CHINESE JOURNAL OF RADIOLOGY , 编辑部邮箱 ,1994年10期
- 【分类号】R735.705
- 【被引频次】16
- 【下载频次】54